SRC-2 Regulates Brain Endothelial and Neuronal Metabolism in a Mouse Model of Neurodegeneration
International Journal of Molecular Sciences · 06.11.2026 · 27 (21) · 9943
DOI: 10.3390/ijms27219943 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 06.11.2026. Verfasst von Rohit K Srivastava und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, TX 77030, USA. Hauptthemen laut MEDLINE: Neurons, Brain, Endothelial Cells, Neurodegenerative Diseases. Die Arbeit nennt 61 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NICHD NIH HHS, National Institutes of Health.
Abstract (Originalsprache)
Cerebrovascular dysfunction and impaired brain energy metabolism are increasingly recognized as important contributors to neurodegenerative diseases, but their molecular regulators remain poorly understood. Here, we examined the roles of steroid receptor coactivator-2 (SRC-2/NCOA2) in the cerebrovascular and metabolic changes associated with neurodegeneration using ps19 mice as a model. In our study, we found a significant decrease in cortical SRC-2 expression in ps19 mice compared with wild-type (WT) controls, with no changes in SRC-1 and SRC-3 levels between the two groups. ps19 mice showed reduced cortical endothelial and blood–brain barrier-associated markers (CD31, occludin, claudin-5, total eNOS (endothelial nitric oxide synthase), and eNOS Ser1177) and increased eNOS Thr495 phosphorylation. HIF-1α, GLUT2, and GLUT4 were also reduced in ps19 mice, whereas GLUT1 and GLUT3 were unchanged between the groups. To examine the role of SRC-2, we used siRNA to reduce its expression in brain endothelial cells and primary neurons. In brain endothelial cells, SRC-2 knockdown reduced the expression of endothelial and BBB-associated markers, including CD31 and occludin, as well as GLUT3, while increasing inhibitory eNOS Thr495 phosphorylation and GLUT4 expression. In brain endothelial cells, SRC-2 knockdown significantly reduced the extracellular acidification rate (ECAR) and NAD+/NADH ratio. Knockdown of SRC-2 in primary neurons (from WT and ps19 mice) significantly reduced the oxygen consumption rate (OCR), while the NAD+/NADH ratio remained unchanged. These findings identify SRC-2 as a regulator of endothelial and neuronal metabolism and support further investigation of SRC-2-dependent pathways as potential therapeutic targets in neurodegenerative diseases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, TX 77030, USA.
ORCID-Profile: David M Lonard
Förderung
- NICHD NIH HHS
- National Institutes of Health
Zitieren
APA
Srivastava, R. K., Singh, P., Jonsson, E. S., Saleem, I., Desales, C. J. P., & Lonard, D. M. (2026). SRC-2 Regulates Brain Endothelial and Neuronal Metabolism in a Mouse Model of Neurodegeneration. International Journal of Molecular Sciences, 27(21), 9943. https://doi.org/10.3390/ijms27219943
Vancouver
Srivastava RK, Singh P, Jonsson ES, Saleem I, Desales CJP, Lonard DM. SRC-2 Regulates Brain Endothelial and Neuronal Metabolism in a Mouse Model of Neurodegeneration. International Journal of Molecular Sciences. 2026;27(21):9943. doi:10.3390/ijms27219943
BibTeX
@article{Srivastava2026,
author = {Srivastava, Rohit K and Singh, Pratibha and Jonsson, Emir S and Saleem, Irfana and Desales, Caycel J P and Lonard, David M},
title = {SRC-2 Regulates Brain Endothelial and Neuronal Metabolism in a Mouse Model of Neurodegeneration},
journal = {International Journal of Molecular Sciences},
year = {2026},
volume = {27},
number = {21},
pages = {9943},
doi = {10.3390/ijms27219943}
}
EUVIMED